| Structure |
Chemical Name |
CAS |
MF |
 |
(3S,5S)-アトルバスタチンアセトニドTERT-ブチルチルエステル |
472967-95-6 |
C40H47FN2O5 |
 |
Afatinib Impurity 68 |
|
|
 |
Nintedanib Impurity 27 |
|
|
 |
Atorvastatin Calcium Hydrate impurity 39 |
2243639-97-4 |
C33H35FN2O5 |
 |
Rivaroxaban Impurity 22 |
|
|
 |
Ceftazidime side chain Impurity |
|
|
 |
3,4-DICHLOROBENZYLAMINE HYDROCHLORIDE |
49552-34-3 |
C7H8Cl3N |
 |
Celecoxib Impurity 17 |
2247197-65-3 |
C17H14F3N3O4S |
 |
ヘルバセチン-3,8-ジグルコピラノシド |
99224-12-1 |
C27H30O17 |
 |
Lincomycin sulfoxide Impurity 3 |
|
|
 |
Bortezomib Impurity W |
|
|
 |
N-(3-chloro-4-fluorophenyl)-6 ,7-dimethoxyquinazolin-4-amine |
153437-78-6 |
C16H13ClFN3O2 |
 |
Ticagrelor Impurity 13 |
|
|
 |
Emtricitabine Impurity CFTU1 |
|
|
 |
Avatrombopag Impurity 31 |
|
|
 |
Caspofungin Impurity EJT2 |
|
|
 |
ニトロスカネイト |
19881-18-6 |
C13H8N2O3S |
 |
Olopatadine impurity |
3112735-87-9 |
C20H20N2O4 |
 |
2-Fluoro-α-(2-methyl-1-oxopropyl)-γ-oxo-N,β-diphenyl-benzenebutanamide |
1797905-42-0 |
C26H24FNO3 |
 |
Daptomycin Impurity 3 |
|
|
![3-[(Dimethylamino)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one](/CAS/GIF/153139-56-1.gif) |
3-[(Dimethylamino)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one |
153139-56-1 |
C16H20N2O |
![2-Naphthalenamine, N-(diphenylmethylene)-6-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5-[2-[tris(1-methylethyl)silyl]ethynyl]-](/CAS/20210305/GIF/2816821-08-4.gif) |
2-Naphthalenamine, N-(diphenylmethylene)-6-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5-[2-[tris(1-methylethyl)silyl]ethynyl]- |
2816821-08-4 |
C40H47BFNO2Si |
 |
Bisoprolol Impurity 47 |
|
|
 |
DecitaBine Impurity 11 |
|
|
 |
Atracurium Impurity W |
|
|
![Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R,5S)-tetrahydro-4-hydroxy-5-methyl-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester](/CAS/20200331/GIF/477877-98-8.gif) |
Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R,5S)-tetrahydro-4-hydroxy-5-methyl-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester |
477877-98-8 |
C26H40O5 |
 |
(S,R)-Palonosetron N-Oxide |
|
C19H24N2O2 |
 |
PalBociclib Impurity 24 |
|
|
![3-[(2-[(E)-2-(3-ETHYL-1,3-BENZOTHIAZOL-3-IUM-2-YL)ETHENYL]-6-((E)-2-[3-ETHYL-1,3-BENZOTHIAZOL-2(3H)-YLIDENE]ETHYLIDENE)-4-METHYL-1-CYCLOHEXEN-1-YL)OXY]-1-PROPANESULFONATE](/StructureFile/ChemBookStructure21/GIF/CB8801272.gif) |
3-[(2-[(E)-2-(3-ETHYL-1,3-BENZOTHIAZOL-3-IUM-2-YL)ETHENYL]-6-((E)-2-[3-ETHYL-1,3-BENZOTHIAZOL-2(3H)-YLIDENE]ETHYLIDENE)-4-METHYL-1-CYCLOHEXEN-1-YL)OXY]-1-PROPANESULFONATE |
|
C32H36N2O4S3 |
![1-(2-フルオロベンジル)-1H-ピラゾロ[3,4-b]ピリジン-3-カルボアミド](/CAS/20150408/GIF/256376-62-2.gif) |
1-(2-フルオロベンジル)-1H-ピラゾロ[3,4-b]ピリジン-3-カルボアミド |
256376-62-2 |
C14H11FN4O |
 |
Tofacitinib Impurity 105 |
|
|
 |
Posaconazole Impurity 75 |
|
|
 |
Sugammadex sodium Monoiodo Impurity |
|
|
 |
Sitafloxacin Impurity ZZ-B-01 |
|
|
 |
5-methyl-2-(2-methylbutyl)phenol |
|
C12H18O |
 |
2-amino-3,5-dibromo-N-((1r,4r)-4-hydroxycyclohexyl)benzamide |
105735-86-2 |
C13H16Br2N2O2 |
 |
Tenofovir Impurity 113 |
1335287-28-9 |
C11H13IN4O |
 |
Pramipexole impurity II |
|
|
![(7a,17b)-7-7-[9-[(4,4,5,5,5-Pentafluoropentyl)sulfinyl]nonyl]-estra-1,3,5(10)-triene-3,17-diol 17-acetate](/CAS/20180808/GIF/261506-24-5.gif) |
(7a,17b)-7-7-[9-[(4,4,5,5,5-Pentafluoropentyl)sulfinyl]nonyl]-estra-1,3,5(10)-triene-3,17-diol 17-acetate |
261506-24-5 |
C34H49F5O4S |
 |
Valsartan cyano analog methyl ester |
137863-90-2 |
C25H30N2O3 |
 |
Entecavir Impurity 5 |
84868-56-4 |
C21H20O2 |
 |
Aprepitant iMpurity 45 |
|
|
![N-[2-(acetyloxy)propyl]-N-[3-[4-(1,1-diMethylpropyl)phenyl]-2-Methylpropyl]-forMaMide](/CAS/20150408/GIF/142347-84-0.gif) |
N-[2-(acetyloxy)propyl]-N-[3-[4-(1,1-diMethylpropyl)phenyl]-2-Methylpropyl]-forMaMide |
142347-84-0 |
C21H33NO3 |
 |
2-amino-4-fluoro-5-nitrobenzoic acid |
1194097-41-0 |
C7H5FN2O4 |
 |
N-((4-(5-Methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)acetaMide |
198471-06-6 |
C18H16N2O4S |
 |
2-クロロ-N-(2,3-ジメチルフェニル)アセトアミド |
2564-07-0 |
C10H12ClNO |
 |
Vonoprazan Impurity 9 |
|
|
 |
オリビル 4-O-グルコシド |
76880-93-8 |
C26H34O12 |
 |
Hydroxy Adapalene |
1346599-76-5 |
C28H28O4 |
 |
9'-DESMETHYL GRANISETRON (グラニセトロン不純物C) |
160177-67-3 |
C17H22N4O |
 |
Vehicle exhaust detection standard gas |
|
|
 |
2-(4-ヒドロキシフェニル)-5-ヒドロキシ-3,7-ビス(β-D-グルコピラノシルオキシ)-4H-1-ベンゾピラン-4-オン |
25615-14-9 |
C27H30O16 |
 |
Eliglustat intermediate 3 |
491833-26-2 |
C23H28N2O5 |
![(2R,3R)-2-[(1S)-1-[3,5-Bis(trifluoroMethyl)phenyl]ethoxy]-3-(4-fluorophenyl)Morpholine hydrochloride](/CAS/20150408/GIF/1333998-21-2.gif) |
(2R,3R)-2-[(1S)-1-[3,5-Bis(trifluoroMethyl)phenyl]ethoxy]-3-(4-fluorophenyl)Morpholine hydrochloride |
1333998-21-2 |
C20H19ClF7NO2 |
 |
Rocuronium Bromide Intermediate B Impurity E-1 |
1190105-60-2 |
C29H48N2O3 |
 |
((2R,3S,4R,5R,6S)-6-(3-((5-(4-fluorophenyl)thiophen-2-yl) methyl)-4-methylphenyl)-3,4,5-trihydroxytetrahydro- 2H-pyran-2-yl)methyl acetate |
2146135-87-5 |
C26H27FO6S |
 |
N-(2-Succinyl) Fluvoxamine |
259526-43-7 |
C19H25F3N2O6 |
 |
Topiroxostat Impurity 4 |
|
|
 |
Epalrestat Impurity 4 |
130786-32-2 |
C8H9NO3S2 |
 |
Oseltamivir Impurity 103 |
|
|
 |
Isavuconazole Impurity 27 |
|
|
 |
Liquiritigenin-7-O-apiosyl(1-2)-glucoside |
135432-48-3 |
C26H30O13 |
![1H-benzo[d][1,2,3]triazol-1-yl 2-fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoate](/) |
1H-benzo[d][1,2,3]triazol-1-yl 2-fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoate |
|
|
 |
Levothyroxine EP Impurity B |
1628720-66-0 |
C15H11ClI3NO4 |
 |
Ganciclovir EP Impurity H |
84222-50-4 |
C9H13N5O4 |
 |
Peramivir Amino Carboxylic Isomerism Impurity |
|
|
 |
Ticagrelor Related Compound 38D-Tartrate |
2165881-71-8 |
C10H19NO4 |
 |
Ornidazole Impurity J |
742020-47-9 |
C7H12N4O3 |
 |
Itraconazole iMpurity D |
|
|
 |
(4S,6R)-6-(Cyanomethyl)-2,2-dimethyl-1,3-dioxane-4-acetic Acid tert-Butyl Ester |
186508-95-2 |
C14H23NO4 |
 |
3-(9H-Carbazol-4-yloxy)-1,2-propanediol |
123119-89-1 |
C15H15NO3 |
 |
Amifostine Impurity 3 |
41510-53-6 |
C5H15N2O3PS |
 |
Bosutinib Impurity |
380843-12-9 |
C19H15Cl2N3O3 |
 |
Topiroxostat Impurity 14 |
|
|
 |
Tolvaptan Impurity 11 |
331947-69-4 |
C16H14ClNO2 |
![[2R,2'S,αS,α'S,(-)]-α,α'-[イミノビス(メチレン)]ビス(6-フルオロ-3,4-ジヒドロ-2H-1-ベンゾピラン-2-メタノール)](/CAS/GIF/118457-16-2.gif) |
[2R,2'S,αS,α'S,(-)]-α,α'-[イミノビス(メチレン)]ビス(6-フルオロ-3,4-ジヒドロ-2H-1-ベンゾピラン-2-メタノール) |
118457-16-2 |
C22H25F2NO4 |
 |
Terbutaline Impurity |
1226543-90-3 |
C22H20O4 |
 |
2-hydroxy-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzonitrile |
|
|
 |
N-(4-methoxy-5-((3-((4-methoxy-2-(4-(3-methoxyazetidin-1-yl)piperidin-1-yl)-5-((6-(1-methyl-1H-indazol-5-yl)pyrimidin-4-yl)amino)phenyl)amino)-3-oxopropyl)amino)-2-(4-(3-methoxyazetidin-1-yl)piperidin-1-yl)phenyl)acrylamide |
|
|
 |
4-メチルピペラジン-1-カルボン酸エチル |
59325-11-0 |
C8H16N2O2 |
 |
2-アミノ-5-ブロモベンズアルデヒド |
29124-57-0 |
C7H6BrNO |
![Benzenepropanoic acid, α-[(cyclopropylamino)methylene]-2,4-difluoro-3-methoxy-β-oxo-, ethyl ester, (αZ)-](/CAS/20210305/GIF/951313-24-9.gif) |
Benzenepropanoic acid, α-[(cyclopropylamino)methylene]-2,4-difluoro-3-methoxy-β-oxo-, ethyl ester, (αZ)- |
951313-24-9 |
C16H17F2NO4 |
 |
(S)-BoroLeu-(-)-Pinanediol-hydrochloride |
945606-99-5 |
C15H28BNO2.ClH |
 |
Rocuronium Bromide Impurity 24 、25 |
|
|
 |
Atomoxetine impurity D CRS |
873310-29-3 |
C17H21NO |
 |
Nicorandil Impurity 2 |
|
|
 |
3-アミノ-4-ピラゾールカルボニトリル |
16617-46-2 |
C4H4N4 |
 |
Levofloxacin Impurity 24 |
|
C18H20FN3O4 |
 |
Lenvatinib Impurity 2 |
2380197-90-8 |
C28H22ClN5O5 |
 |
Ambroxol Impurity 8(Ambroxol Impurity M) |
1445719-53-8 |
C13H16Br2N2O |
![Benzoic acid, 5-(aminosulfonyl)-2-[[[4-methoxy-3-(methoxycarbonyl)phenyl]sulfonyl]oxy]-, methyl ester](/CAS/20210305/GIF/2267259-70-9.gif) |
Benzoic acid, 5-(aminosulfonyl)-2-[[[4-methoxy-3-(methoxycarbonyl)phenyl]sulfonyl]oxy]-, methyl ester |
2267259-70-9 |
C17H17NO10S2 |
 |
Rosuvastatin Impurity 138 |
|
|
 |
N-メチル-4-(3,4-ジクロロフェニル)テトラリン-1-アミン |
140631-53-4 |
C17H17Cl2N |
 |
(R)-N-((S)-2-aminobutanoyl)-3-(bromomethyl)hexanamide |
|
C11H21BrN2O2 |
 |
Trelagliptin Impurity 20 |
1821520-42-6 |
C20H22FN5O3 |
 |
Bumetanide Impurity 10 |
|
|
 |
N-(4-methyl-3-((5-(pyridin-3-yl) |
|
|
 |
Canagliflozin Impurity 48 |
|
|
 |
3-Morpholinone, 4-(2,4-diaMinophenyl)- |
482308-13-4 |
C10H13N3O2 |
![2-メトキシ-4-[(E)-1-プロペニル]フェノール](/CAS/GIF/5932-68-3.gif) |
2-メトキシ-4-[(E)-1-プロペニル]フェノール |
5932-68-3 |
C10H12O2 |